Education
About Us
Working with TipRanks
Follow Us
Avita Medical Ltd (RCEL)
:RCEL
RCEL Stock Chart & Stats
$4.12
-$5.13(-36.49%)
At close: 4:00 PM EST
$4.12
-$5.13(-36.49%)
Day’s Range― - ―
52-Week Range$3.25 - $14.16
Previous CloseN/A
Volume824.49K
Average Volume (3M)194.17K
Market Cap
$99.71M
Enterprise Value$0.00
Total Cash (Recent Filing)$23.31M
Total Debt (Recent Filing)$44.77M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Feb 19, 2026EPS Estimate
-0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding30,493,110
10 Day Avg. Volume182,619
30 Day Avg. Volume194,168
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)73.64
Price to Sales (P/S)5.16
P/FCF Ratio-5.69
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$6.50Price Target Upside57.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market OpportunityThe company is focusing selling efforts on approximately 200 key U.S. burn and trauma centers, which represent the highest-value opportunities in the acute wound care market - an estimated $1.3B opportunity.
Product PortfolioThe commercial focus near-term is disciplined execution across a three-product wound-care portfolio, with a growing funnel of hospital VAC approvals.
Strategic InitiativesManagement used the 3Q earnings call to effectively communicate new strategic initiatives that should drive accelerated revenue growth.
Bears Say
Financial GuidanceRCEL lowered FY25 guidance to $70M-$74M, reflecting expected lower demand and utilization.
Leadership UncertaintyThe CEO transition adds uncertainty, as the company looks for new leadership both internally and externally.
Revenue PerformancePreliminary 3Q'25 revenue is expected at ~$17M, pressured by MAC reimbursement headwinds that persisted longer than anticipated.
Avita Medical News
RCEL FAQ
What was Avita Medical Ltd’s price range in the past 12 months?
Avita Medical Ltd lowest stock price was $3.25 and its highest was $14.16 in the past 12 months.
What is Avita Medical Ltd’s market cap?
Avita Medical Ltd’s market cap is $99.71M.
When is Avita Medical Ltd’s upcoming earnings report date?
Avita Medical Ltd’s upcoming earnings report date is Feb 19, 2026 which is in 61 days.
How were Avita Medical Ltd’s earnings last quarter?
Avita Medical Ltd released its earnings results on Nov 06, 2025. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.332 by -$0.128.
Is Avita Medical Ltd overvalued?
According to Wall Street analysts Avita Medical Ltd’s price is currently Undervalued.
Does Avita Medical Ltd pay dividends?
Avita Medical Ltd does not currently pay dividends.
What is Avita Medical Ltd’s EPS estimate?
Avita Medical Ltd’s EPS estimate is -0.35.
How many shares outstanding does Avita Medical Ltd have?
Avita Medical Ltd has 30,493,110 shares outstanding.
What happened to Avita Medical Ltd’s price movement after its last earnings report?
Avita Medical Ltd reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.332. Following the earnings report the stock price went up 10.882%.
Which hedge fund is a major shareholder of Avita Medical Ltd?
Currently, no hedge funds are holding shares in RCEL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Avita Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.50 (57.77% Upside)
$6.50 (57.77% Upside)
Blogger Sentiment
Bullish
RCEL Sentiment 70%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 14.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $113.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 4.4%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.93%
12-Months-Change
Fundamentals
Return on Equity
-1746.27%
Trailing 12-Months
Asset Growth
-21.37%
Trailing 12-Months
Company Description
Avita Medical Ltd
Avita Medical (RCEL) is a regenerative medicine company focused on developing and commercializing innovative therapies for the treatment of wounds and skin defects. The company operates primarily in the healthcare sector, specializing in advanced wound care solutions. Its core product, the RECELL System, is designed for the treatment of burns, chronic wounds, and other skin conditions by enabling the rapid preparation of skin grafts directly from a small sample of the patient’s own skin.
RCEL Company Deck
RCEL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in reimbursement issues and cost management, alongside strategic expansions in Europe. However, these positive developments were offset by notable revenue declines, reduced revenue guidance, and financial adjustments indicating ongoing challenges. Despite improvements in operational efficiency and cash management, the financial outlook remains cautious.View all RCEL earnings summariesRCEL Revenue Breakdown
99.27% Commercial sales
0.67% Services for emergency preparedness
0.07% Deferred commercial revenue
RCEL Stock 12 Month Forecast
Average Price Target
$6.50
▲(57.77% Upside)
Technical Analysis
Ownership Overview
1.20% Insiders
7.27% Mutual Funds
1.58% Other Institutional Investors
84.10% Public Companies and
Individual Investors